P2.04-91 Target Antigen Levels in NSCLC Define a Clinically Relevant Activation Threshold for NY-ESO-1c259 TCR T-Cell Therapy
Eleftheriadou, I., Brett, S., Domogala, A., Patasic, L., Kijewska, M., Soor, K., Jing, J., Euesden, J., Auger, K., Roberts, R., O’sullivan, S., Castelletti, L., Damm, M., Klapwijk, J., Spaull, J., PanVolume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1596
Date:
October, 2019
File:
PDF, 304 KB
2019